Renal Cell Carcinoma

Molecular Targets and Clinical Applications, Second Edition

Nonfiction, Health & Well Being, Medical, Specialties, Radiology & Nuclear Medicine, Oncology
Cover of the book Renal Cell Carcinoma by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781597453325
Publisher: Humana Press Publication: February 8, 2009
Imprint: Humana Language: English
Author:
ISBN: 9781597453325
Publisher: Humana Press
Publication: February 8, 2009
Imprint: Humana
Language: English

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

More books from Humana Press

Cover of the book Beyond Anthrax by
Cover of the book Colorectal Cancer Screening by
Cover of the book Modern Hematology by
Cover of the book Shoulder Dystocia and Birth Injury by
Cover of the book Highly Selective Neurotoxins by
Cover of the book Aging, Heart Disease, and Its Management by
Cover of the book Signaling Networks and Cell Cycle Control by
Cover of the book Hyperlipidemia in Primary Care by
Cover of the book Flotation Technology by
Cover of the book Pulmonary Arterial Hypertension and Interstitial Lung Diseases by
Cover of the book Infectious Disease in the Aging by
Cover of the book Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy by
Cover of the book Interventional Radiology of the Spine by
Cover of the book Challenging Cases in Endocrinology by
Cover of the book Electronic Medical Records by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy